Use of a kras g12c inhibitor in treating cancers

TW202635311APending Publication Date: 2026-09-01AMGEN INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115101141
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-05-17
Filing Date
2022-01-07
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001075127_001
    Figure TWG2TA001075127_001
  • Figure TWG2TA001075127_002
    Figure TWG2TA001075127_002
  • Figure TWG2TA001075127_003
    Figure TWG2TA001075127_003
Patent Text Reader

Abstract

The present disclosure provides uses for a KRASG12C inhibitor, such as the compound of Formula I (AMG
Need to check novelty before this filing date? Find Prior Art